Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone for Early Regression of Albuminuria in T2DM and CKD
NCT07667517Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jul 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07667517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07667517.